Contents of matrix metalloproteinase type 2 (MMP-2) and complexes MMP-9/TIMP-1, MMP-2/TIMP-2, and total cholesterol in practically healthy people and patients with hypertension

封面

如何引用文章

全文:

详细

Arterial hypertension (AH) is the most common age-associated disease among the working population. Polyetiology of AH requires a more thorough definition and study of its predictors aiming for understanding the role of external influences, as well as detection of genetic polymorphisms at early stages, in order to limit their implementation. The scientific reviews discuss the important role of abnormal vascular remodeling in the pathogenesis of hypertension. The main factor of such alterations is the rearrangement of extracellular matrix due to matrix metalloproteinases (MMP), the zinc-dependent enzymes with a wide substrate specificity. In addition, in more than 70% of cases, AH is combined with lipid metabolism disorders, including an increase in cholesterol levels. These mechanisms should be taken into account when assessing risk factors for development of cardiovascular accidents. The role of MMP-2 and the complexes MMP- 9/ TIMP- 1, MMP-2/TIMP-2 in pathogenesis of vascular restructuring is insufficiently described in the review articles. The article presents our results of studying the system of proteolytic enzymes and the level of total cholesterol in 110 practically healthy people and 90 persons with AH aged 18 to 74 years old. The levels of MMP-2, MMP-9/ TIMP- 1, MMP-2/TIMP-2 complexes in blood serum were studied by the sandwich variant of ELISA technique. Statistical processing of the obtained data was carried out using the analytical software IBM SPSS Statistics, v. 22.0.1. It was found that in the groups of women, regardless of the presence, or absence of pathology, the level of total cholesterol is higher if compared with male subjects. MMP-2 values were low both in the general group of practically healthy people, regardless of gender, and in the group of men with hypertension. Proteolytic activity of MMP-2 shows a broader substrate activity in women with hypertension. In the group of practically healthy men and women, we have registered lower levels of the studied MMP complexes and their tissue inhibitors. An imbalance in the proteolysis/antiproteolysis system is observed both in the group of hypertensive women with more pronounced effects upon migration, proliferation and apoptosis of smooth muscle cells, endothelial and inflammatory cells, thus determining formation of intima and arterial remodeling, as well as in the group of men with hypertension with predominance of remodeling factors that affects the rigidity of vascular wall.

作者简介

Natalya Chepurnova

Pacific State Medical University

编辑信件的主要联系方式.
Email: Dr.cns@yandex.ru
ORCID iD: 0000-0001-6642-1332

PhD (Medicine), Associate Professor, Department of Normal and Pathological Physiology, Pacific State Medical University

俄罗斯联邦, Vladivostok

S. Knysh

Pacific State Medical University

Email: s.knysh@m.tgmu.ru

PhD (Medicine), Associate Professor, Department of Normal and Pathological Physiology, Pacific State Medical University

俄罗斯联邦, Vladivostok

V. Yushchuk

Pacific State Medical University

Email: Dr.cns@yandex.ru

Assistant Professor, Department of Public Health and Public Health, Pacific State Medical University

俄罗斯联邦, Vladivostok

E. Markelova

Pacific State Medical University

Email: markev2010@mail.ru

PhD, MD (Medicine), Professor, Head, Department of Normal and Pathological Physiology, Pacific State Medical University

俄罗斯联邦, Vladivostok

K. Sanatsky

Pacific State Medical University

Email: Dr.cns@yandex.ru

Student, Medical Faculty, Pacific State Medical University

俄罗斯联邦, Vladivostok

A. Yushchenko

Pacific State Medical University

Email: Dr.cns@yandex.ru

Student, Medical Faculty, Pacific State Medical University

俄罗斯联邦, Vladivostok

M. Yermolitskaya

Institute of Automation and Control Processes, Far Eastern Branch, Russian Academy of Sciences

Email: Dr.cns@yandex.ru

PhD (Biology), Senior Research Associate, Laboratory of Information-Analytical and Control Systems and Technologies, Institute of Automation and Control Processes, Far Eastern Branch, Russian Academy of Sciences

俄罗斯联邦, Vladivostok

参考

  1. Грачев Н.И., Красников В.Е., Турмова Е.П., Маркелова Е.В., Рублев В.Ю., Назаренко С.А. Анализ показателей матриксной металлопротеиназы-9, тканевого ингибитора матриксных металлопротеиназ 1-го типа и их комплекса у пациентов с острым инфарктом миокарда, подвергшихся чрескожным коронарным вмешательствам // Тихоокеанский медицинский журнал, 2018. № 4 (74). С. 45-48. [Grachev N.I., Krasnikov V.E., Turmova E.P., Markelova E.V., Rublev V.Yu., Nazarenko S.A. Аnalysis of matrix metalloproteinase-9, tape inhibitor of matrix metalloproteinase type 1 and their complex in patients with acute miocard infarction who have exposed high coronary interventions. Tikhookeanskiy meditsinskiy zhurnal = Pacific Medical Journal, 2018, no. 4 (74), pp. 45-48. (In Russ.)]
  2. Литвинова М.С., Хаишева Л.А., Шлык С.В., Абоян И.А. Активность матриксной металлопротеиназы типа 9 и её связь с выраженностью кальцификации грудной аорты у пациентов с резистентной артериальной гипертензией: одномоментное сравнительное исследование // CardioСоматика, 2022. Т. 13, № 3. С. 148-155. [Litvinova M.S., Khaisheva L.A., Shlyk S.V., Aboyan I.A. The activity of matrix metalloproteinase type 9 and its relationship with the severity of calcification of the thoracic aorta in patients with resistant hypertension: a one-stage comparative study. CardioSomatika = CardioSomatics, 2022, Vol. 13, no. 3, pp. 148-155. (In Russ.)]
  3. Михин В.П., Осипова О.А., Воротынцева В.В., Перуцкий Д.Н., Головина Н.И. Содержание матриксных металлопротеиназ в крови больных артериальной гипертонией с высоким сердечно-сосудистым риском на фоне терапии статинами // Кардиоваскулярная терапия и профилактика, 2022. Т. 21, № 10, 3422. [Mikhin V.P., Osipova O.A., Vorotyntseva V.V., Perutsky D.N., Golovina N.I. The content of matrix metalloproteinases in the blood of patients with arterial hypertension with high cardiovascular risk on the background of statin therapy. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention, 2022, Vol. 21, no. 10, 3422. (In Russ.)] doi: 10.15829/1728-8800-2022-3422.
  4. Москаленко М.И. Вовлеченность генов матриксных металлопротеиназ в развитиии аретриальной гипертензии и ее осложений // Научные результаты биомедицинских исследований, 2018. Т. 4, № 1. С. 53-59. [Moskalenko M.I. The involvement of genes of matrix metalloproteinases in the development of arteial hypertension and its complication (review). Nauchnye rezultaty biomeditsinskikh issledovaniy = Research Result. Medicine and Pharmacy, 2018, Vol. 4, no. 1, pp. 53-69. (In Russ.)]
  5. Плехова Н.Г., Невзорова В.А., Родионова Л.В., Лагурева А.В., Масленникова К.К., Цыганков М.А., Дубов В.С. Показа липопротеинового метаболизма у пациентов молодого возраста с артериальной гипертонией // Вестник современной клинической медицины, 2019. Т. 12, вып. 4. С. 44-51. [Plekhova N.G., Nevzorova V.A., Rodionova L.V., Lagureva A.V., Maslennikova K.K., Tsygankov M.A., Dubov V.S. Indications of lipoprotein metabolism in young patients with arterial hypertension. Vestnik sovremennoy klinicheskoy meditsiny = Bulletin of Modern Clinical Medicine, 2019, Vol. 12, Iss. 4, pp. 44-51. (In Russ.)]
  6. Chang C.-H., Yeh S.-T., Ooi S.-W., Li C.-Y., Chen. H.-F. The relationship of low-density lipoprotein cholesterol and all-cause or cardiovascular mortality in patients with type 2 diabetes: a retrospective study. PeerJ, 2023, Vol. 11, e14609. doi: 10.7717/peerj.14609.
  7. Prado A.F., Batista R.I.M., Tanus-Santos J.E., Gerlach R.F. Matrix Metalloproteinases and arterial hypertension: role of oxidative stress and nitric oxide in vascular functional and structural alterations. Biomolecules, 2021, Vol. 11, no. 4, 585. doi: 10.3390/biom11040585.
  8. Valente F.M., de Andrade D.O., Cosenso-Martin L.N., Cesarino C.B., Guimarães S.M., Guimarães V.B., Lacchini R., Tanus-Santos J.E., Yugar-Toledo J.C., Vilela-Martin J.F. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis. BMC Cardiovasc Disord., 2020, Vol. 20, no. 1, 132. doi: 10.1186/s12872-020-01412-5.

版权所有 © Чепурнова Н., Кныш С., Ющук В., Маркелова Е., Санацкий К., Ющенко А., Ермолицкая М., 2023

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
##common.cookie##